Analyst Ratings for Teva Pharma (TEVA) [Buys]
TEVA Rating Summary
TEVA Price Target Summary
- Highest: $65.00 (Standpoint Research)
- Lowest: $42.00 (Barclays)
- Average: $46.79
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$46.79 (+20.1%)
Avg. $ Target:
$46.79 (+20.1%)
| Date | Firm | Type | Rating (Past) |
PT (Past) |
Start $ | End $ | % Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 5/10/2013 | BMO Capital | New Coverage | Outperform (N/A) |
N/A (N/A) |
38.87 | 38.96 | 0.23% | Details |
| 11/17/2011 | Deutsche Bank » Updated 6/18/2012 |
New Coverage | Buy (N/A) |
48.00 (N/A) |
40.03 | 38.96 | -2.67% | Details |
| 11/8/2011 | Credit Suisse | New Coverage | Outperform (N/A) |
53.00 (N/A) |
41.72 | 38.96 | -6.62% | Details |
| 5/9/2011 | Bernstein | Upgrade | Outperform (N/A) |
N/A (N/A) |
47.08 | 38.96 | -17.25% | Details |
| 4/25/2011 | Gabelli » Updated 4/25/2011 |
Upgrade | Buy (N/A) |
N/A (N/A) |
45.01 | 38.96 | -13.44% | Details |
| 12/22/2010 | Ameriprise Financial | New Coverage | Buy (N/A) |
N/A (N/A) |
51.10 | 38.96 | -23.76% | Details |
| 8/16/2010 | Credit Agricole | Upgrade | Buy (N/A) |
N/A (N/A) |
49.97 | 38.96 | -22.03% | Details |
